[18F]FDG PET immunotherapy radiomics signature (iRADIOMICS) predicts response of non-small-cell lung cancer patients treated with pembrolizumab
Authors
Damijan Valentinuzzi
Jožef Stefan Institute, Ljubljana, Slovenia
Faculty of Mathematics and Physics, University of Ljubljana, Ljubljana, Slovenia
Martina Vrankar
Institute of Oncology Ljubljana, Ljubljana, Slovenia
Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia
Nina Boc
Institute of Oncology Ljubljana, Ljubljana, Slovenia
Valentina Ahac
Institute of Oncology Ljubljana, Ljubljana, Slovenia
Ziga Zupancic
Institute of Oncology Ljubljana, Ljubljana, Slovenia
Mojca Unk
Institute of Oncology Ljubljana, Ljubljana, Slovenia
Katja Skalic
Institute of Oncology Ljubljana, Ljubljana, Slovenia
Ivana Zagar
Institute of Oncology Ljubljana, Ljubljana, Slovenia
Andrej Studen
Jožef Stefan Institute, Ljubljana, Slovenia
Faculty of Mathematics and Physics, University of Ljubljana, Ljubljana, Slovenia
Urban Simoncic
Jožef Stefan Institute, Ljubljana, Slovenia
Faculty of Mathematics and Physics, University of Ljubljana, Ljubljana, Slovenia
Jens Eickhoff
Department of Biostatistics and Medical Informatics, University of Wisconsin, Madison, USA
Robert Jeraj
Jožef Stefan Institute, Ljubljana, Slovenia
Faculty of Mathematics and Physics, University of Ljubljana, Ljubljana, Slovenia
Department of Medical Physics, University of Wisconsin, Madison, USA
Language: English
Page range: 285 - 294
Submitted on: Apr 30, 2020
Accepted on: Jun 5, 2020
Published on: Jul 29, 2020
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:
© 2020 Damijan Valentinuzzi, Martina Vrankar, Nina Boc, Valentina Ahac, Ziga Zupancic, Mojca Unk, Katja Skalic, Ivana Zagar, Andrej Studen, Urban Simoncic, Jens Eickhoff, Robert Jeraj, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.